XML 49 R41.htm IDEA: XBRL DOCUMENT
v3.22.1

License Agreement - Additional Information (Details) - License Agreement | 3 Months Ended
--- | ---
Mar. 31, 2022 USD ($)
Schedule Of License Agreement [Line Items] |
Upfront payment upon execution of agreement | $ 100,000
Written notice period for termination of agreement | 90 days
Termination period Description | WARF may terminate the License Agreement with 90 days written notice if first commercial sale does not occur before December 31, 2031. Unless terminated earlier by the parties, the term of the License Agreement will continue until the last licensed patent expires in all countries.
Investigation New Drug (IND) | Maximum |
Schedule Of License Agreement [Line Items] |
Expected milestone payment on achieving certain regulatory and commercial milestones | $ 17,500,000
Investigation New Drug (IND) | Minimum [Member] |
Schedule Of License Agreement [Line Items] |
Expected royalty payments upon first commercial product sale | 100,000
Research and Development |
Schedule Of License Agreement [Line Items] |
Payment for upfront fee | $ 300,000

X
- Definition Collaborative arrangements upfront payment. + References No definition available. + Details
Name: | dsgn_CollaborativeArrangementsUpfrontPayment
Namespace Prefix: | dsgn_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Expected milestone payment on achieving certain regulatory and commercial milestones. + References No definition available. + Details
Name: | dsgn_ExpectedMilestonePaymentOnAchievingCertainRegulatoryAndCommercialMilestones
Namespace Prefix: | dsgn_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Expected royalty payments upon first commercial product sale. + References No definition available. + Details
Name: | dsgn_ExpectedRoyaltyPaymentsUponFirstCommercialProductSale
Namespace Prefix: | dsgn_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Notice period description. + References No definition available. + Details
Name: | dsgn_NoticePeriodDescription
Namespace Prefix: | dsgn_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Notice period for termination of agreement. + References No definition available. + Details
Name: | dsgn_NoticePeriodForTerminationOfAgreement
Namespace Prefix: | dsgn_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Schedule of license agreement. + References No definition available. + Details
Name: | dsgn_ScheduleOfLicenseAgreementLineItems
Namespace Prefix: | dsgn_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Upfront payment upon execution of agreement. + References No definition available. + Details
Name: | dsgn_UpfrontPaymentUponExecutionOfAgreement
Namespace Prefix: | dsgn_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=dsgn_LicenseAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=dsgn_InvestigationNewDrugMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |